Long-term follow-up of survivors of childhood cancer (SIGN Clinical Guideline 132)

Archives of Disease in Childhood: Education and Practice Edition

Volumn 99, Issue 4, 2014, Pages 138-143

  Gan, Hoong Wei ^a,b   Spoudeas, Helen A ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE DENSITY; CANCER SURVIVAL; CANCER SURVIVOR; CHILD GROWTH; CHILDHOOD CANCER; COGNITIVE DEFECT; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; FERTILITY; FOLLOW UP; HEART; HUMAN; LONG TERM CARE; METABOLIC SYNDROME X; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIMARY TUMOR; PSYCHOSOCIAL DISORDER; SECONDARY HEALTH CARE; SURVIVAL RATE; TERTIARY HEALTH CARE; THYROID DISEASE; UNITED KINGDOM; CHILD; HEALTH; HEALTH CARE DELIVERY; MORTALITY; NEOPLASMS; STANDARDS; TIME; TRENDS;

CHILD; DELIVERY OF HEALTH CARE; FOLLOW-UP STUDIES; GLOBAL HEALTH; HUMANS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; SURVIVAL RATE; TIME FACTORS;

EID: 84908284530     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/archdischild-2013-305452     Document Type: Article

References (28)

1. Gatta G, Capocaccia R, Stiller C, et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 2005;23:3742-51.
2. Office for National Statistics. Cancer statistics registrations: registrations of cancer diagnosed in 2009, England (MB1 40). London: Office for National Statistics, 2011.
3. Stiller CA. Childhood cancer in Britain: incidence, survival, mortality. Oxford: Oxford University Press, 2007.
4. Skinner R, Wallace WH, Levitt G. Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how? Arch Dis Child 2007;92:257-60.
5. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-82.
6. Department of Health, Macmillan Cancer Support, NHS Improvement. Living with and beyond cancer: taking action to improve outcomes. London: National Cancer Survivorship Initiative (NCSI), Department of Health, 2013.
7. Wallace WH, Blacklay A, Eiser C, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ 2001;323:271-4.
8. Scottish Intercollegiate Guidelines Network (SIGN). Long term follow up of survivors of childhood cancer. Edinburgh: SIGN, 2013. (SIGN publication no. 132).
9. Skinner R, Wallace WHB, Levitt GA. eds. Therapy based long-term follow-up. 2nd edn. UK Children's Cancer Study Group (UK CCSG) Late Effects Group, 2005.
10. Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011;305:2311-19.
11. Multidi sciplinary Working Party convened by the British Fertility Society. A strategy for fertility services for survivors of childhood cancer. Hum Fertil (Camb) 2003;6:A1-A39.
12. Gan HW, Spoudeas HA. Preserving reproductive capacity in young boys with cancer. Trends Urol Men's Health 2013;4:8-12.
13. Bahadur G, Ozturk O, Muneer A, et al. Semen quality before and after gonadotoxic treatment. Hum Reprod 2005;20:774-81.
14. Steffens M, Beauloye V, Brichard B, et al. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol (Oxf) 2008;69:819-27.
15. Bull KS, Spoudeas HA, Yadegarfar G, et al. Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG). J Clin Oncol 2007;25:4239-45.
16. Kennedy C, Bull K, Chevignard M, et al. Quality of Survival and Growth in Children and Young Adults in the PNET4 European Controlled Trial of Hyperfractionated Versus Conventional Radiation Therapy for Standard-Risk Medulloblastoma. Int J Radiat Oncol Biol Phys 2014;88: 292-300.
17. Sklar CA, Mertens AC, Mitby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87:3136-41.
18. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: A guideline developer's handbook. Edinburgh: SIGN, 2011.
19. Taylor A, Hawkins M, Griffiths A, et al. Long-term follow-up of survivors of childhood cancer in the UK. Pediatr Blood Cancer 2004;42:161-8.
20. Hjorth L, Kvarnstrom E. Pancare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies. 2013. [cited 2013 2 December 2013]; http://www.pancaresurfup.eu
21. Heirs M, Suekarran S, Slack R, et al. A systematic review of models of care for the follow-up of childhood cancer survivors. Pediatr Blood Cancer 2013;60:351-6.
22. Human Fertilisation and Embryology Act 1990 (modified 2008). London, UK: HMSO, 2008.
23. Muller HL, Gebhardt U, Teske C, et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 2011;165:17-24.
24. Karavitaki N, Brufani C, Warner JT, et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 2005;62:397-409.
25. Spoudeas HA, Albanese A, Saran F, et al. Chapter One- Craniopharyngioma. In: Spoudeas HA, Harrison B. eds. Paediatric endocrine tumours: a multidisciplinary consensus statement of best practice from a working group convened under the auspices of the British Society for Paediatric Endocrinology & Diabetes (BSPED) and United Kingdom Children's Cancer Study Group (UKCCSG) (rare tumour working groups). 1st edn. Crawley, UK: Novo Nordisk Ltd., 2005:16-46.
26. Darzy KH, Shalet SM. Hypopituitarism following radiotherapy. Pituitary 2009;12:40-50.
27. Jereczek-Fossa BA, Alterio D, Jassem J, et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004;30:369-84.
28. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010;304:1365-74.